The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed tislelizumab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.

It is from these cells, which express a gene called Krt5 that helps to build the structure of cells, that lung squamous cell ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Treatment varies by cancer stage; early-stage often involves surgery and chemotherapy, while advanced stages may use immunotherapy. Risk factors differ between squamous cell cancer and adenocarcinoma ...

Pretrained foundation models for diagnosing nonmelanoma skin cancer outperformed baseline machine learning models.

Patients at least 18 years old with primary symptoms of OPD following surgery, chemotherapy, or radiotherapy for the treatment of oropharyngeal squamous cell carcinoma are ... or another non-skin ...

Case presentation: A 59-year-old woman was diagnosed with unresectable squamous cell carcinoma of the lung ... This case report describes a patient with unresectable non-small cell lung cancer who ...

For example, human papillomavirus (HPV) infection is the underlying cause of up to half of squamous cell cancer of the vulva ... condition that can develop into cancer. Early signs of vulvar cancer ...